Skip to main content

Table 2 Medical care Timelines and Clinical Characteresitic of 25 patents with confirmed A (H7N9) virus infection in Guangzhou

From: Factors associated with clinical outcome in 25 patients with avian influenza A (H7N9) infection in Guangzhou, China

Clinical characteristic

Median

Range

Death (Range)

ARDS (Range)

Fatal (n = 14)

Nonfatal (n = 11)

P

No (n = 10)

Yes (n = 15)

P

Time from illness onset to first medical care (days)

1

0–7

1.5 (0–6)

1 (0–7)

0.972

0.5 (0–4)

2 (0–7)

0.059

Time from illness onset to hospitalization (days)

4

0–14

4.5 (0–14)

4 (0–7)

0.783

3.5 (0–7)

5 (0–14)

0.109

Time from illness onset to Confirmation (days)

7

1–14

7 (3–14)

7 (1–13)

0.075

6 (1–13)

7 (3–14)

0.485

Time from illness onset to oseltamivir treatment (days)

5

0–11

6 (0–11)

4 (0–8)

0.802

4 (0–7)

6 (0–11)

0.024

Time of sustained viral sheddinga (days)

3

1–21

2 (2–11)

3 (1–16)

0.42

3 (2–13)

2 (0–21)

0.199

Time from illness onset to development of ARDS (days)

7

2–14

7.5 (2–14)

7 (6–8)

0.661

   

Time from illness onset to development of death (days)

10

2–70

      
  1. aPatients were followed daily in throat swabs or endotracheal secretions in intubated patients by RT-PCR